Please login to the form below

Not currently logged in
Email:
Password:

Cancer deaths in young people in UK drop by 58% in 40 years

Figures released by Cancer Research UK
Cancer deaths in youngsters drops

Fiona Barnett and her son Rufus, 7, who was diagnosed with leukaemia last year

The cancer death rate in children and young people has fallen by 58% in the past 40 years, according to figures released by Cancer Research UK.

During the 1970s there were around 1,300 deaths each year but this has dropped to approximately 550 deaths, with the steepest decline in leukaemia for which figures dropped 39% over the last decade to an average of 110 fatalities.

Despite the promising figures, cancer remains the disease that is the biggest killer of children and young people in the UK with around 550 losing their lives every year.

Professor Pam Kearns, director of the Cancer Research UK clinical trials unit in Birmingham, said: “These figures are testament to the real progress we're making in treating children and young people with cancer.

“Cancer Research UK has been instrumental in this progress but hundreds of young people are dying from cancer each year in the UK, which means there's still much more we need to do.”

The new figures have been revealed as part of the charity's Cancer Research UK Kids & Teens on-going campaign, which aims to fund more research to find better, kinder treatments for children and young people with cancer.

In the UK, approximately 1,600 children and 2,200 teenagers and young adults are diagnosed with cancer each year and the overall ten-year survival for cancer in under 14s has almost tripled since the 1960s, around three quarters of which are now cured.

Harpal Kumar, Cancer Research UK's chief executive, added: “Money raised by Cancer Research UK Kids & Teens will be restricted to research into cancers affecting children, teenagers and young adults, enabling us to better understand these cancers.

“In the next 5-10 years Cancer Research UK hopes to double the amount it spends on these cancers.”

Article by
Kirstie Pickering

27th January 2015

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics